Correlation Between Sight Sciences and Neuropace

Can any of the company-specific risk be diversified away by investing in both Sight Sciences and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sight Sciences and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sight Sciences and Neuropace, you can compare the effects of market volatilities on Sight Sciences and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sight Sciences with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sight Sciences and Neuropace.

Diversification Opportunities for Sight Sciences and Neuropace

-0.02

Correlation Coefficient

Sight Sciences  Neuropace

Good diversification

The 3 months correlation between Sight and Neuropace is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Sight Sciences and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Sight Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sight Sciences are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Sight Sciences i.e., Sight Sciences and Neuropace go up and down completely randomly.

Pair Corralation between Sight Sciences and Neuropace

Given the investment horizon of 90 days Sight Sciences is expected to under-perform the Neuropace. In addition to that, Sight Sciences is 1.3 times more volatile than Neuropace. It trades about -0.08 of its total potential returns per unit of risk. Neuropace is currently generating about 0.06 per unit of volatility. If you would invest  1,087  in Neuropace on December 29, 2024 and sell it today you would earn a total of  98.00  from holding Neuropace or generate 9.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sight Sciences  vs.  Neuropace

Sight Sciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sight Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Neuropace

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sight Sciences and Neuropace

The main advantage of trading using opposite Sight Sciences and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sight Sciences position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind Sight Sciences and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.